Byrd K, Truong P. Bortezomib in the Treatment of Acquired von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance. kjm. 2014;7(4):167-170. doi:10.17161/kjm.v7i4.11507